Health
Ebola Bundibugyo Outbreak Expands to Eight DRC Provinces, Prompting Regional Response
The Democratic Republic of Congo’s Ebola outbreak now spans eight provinces, with over 4,600 deaths and more than 9,500 infections, while neighboring countries launch contact‑tracing and vaccination research.
American Impact Alliance News Desk2 minute read
Widening Impact Across the DRC
Since its declaration in mid‑May, the Bundibugyo Ebola outbreak has been confirmed in eight provinces of the Democratic Republic of Congo, including the newly affected Nord Ubangi province that borders the Central African Republic. Official counts show more than 9,500 confirmed infections and over 4,600 deaths, with roughly six‑tenths of fatalities occurring outside health facilities, highlighting ongoing community transmission. In the remote commune of Mangina in North Kivu, health officials reported 15 deaths per day last week. A WHO emergency response team entered Mangina two weeks ago and began working with local communities despite initial resistance and insecurity.
Cross‑Border Cases Spur Contact‑Tracing Efforts
Nigeria recorded its first case on 7 October in a patient who arrived from Uganda, sought care at a clinic and was hospitalized 48 hours later. Authorities have identified more than 40 close contacts and are reinforcing infection‑prevention measures in both public and private facilities. Kenya, the fifth country this year to confirm the disease, reported nine cases—including one death—after a Kenyan national returned from the DRC via Uganda; 135 contacts linked to the deceased patient have been traced and accounted for. Uganda, which logged two deaths and 20 confirmed infections, declared the Bundibugyo threat over at the end of August.
Vaccine Research and Operational Hurdles
WHO scientists are evaluating the Ervebo vaccine, originally designed for the Zaire strain, to determine whether it offers protection against the Bundibugyo variant circulating in the DRC. Preliminary data on cross‑protection have not yet been released. The response faces logistical challenges, including reaching remote villages, maintaining trust in communities that initially resisted assistance, and ensuring strict infection‑control protocols across health centres. Strengthening surveillance, rapid contact tracing and community engagement remain central to limiting further spread while vaccine research progresses.